You can share it to WeChat via the Qr code.
Enter the applet sharing event using WeChat scan.
As a member of ICH, it marks an significant step of China's drug standards in the worldwide. In order to promote the implementation of ICH guidelines, China launched the MAH system, actively promoted the consistency evaluation of generics, and also issued the technical requirements for injection consistency evaluation. Companies are in the dilemma of how to carry out the policies. Therefore, the industry needs a platform to explore and discuss.
With the rapid development of China's pharmaceutical industry, a series of policies such as “4+7” encourage drug innovation and promote the transformation and production of novel drug research and development. Due to the increasing number of approved drugs in the future, the market for modified formulations is unprecedented. Therefore, it is urgent to strengthen the research and development of modified preparations. At present, the development of Poorly-soluble tablets, sustained-release preparations and preparations refers to novel platforms confront with many stages of challenges in how to increase clinical effectiveness, improve process stability and industrialization.
Therefore, PharmaCon Committee is the top conference platform for Chinese chemical companies, and is committed to promoting the communication in the industry as a whole. PharmaCon2019 as the World-China Pharmaceutical R&D Congress will bring together more than 500 leading domestic and international chemical companies and leaders, to explore Pharmaceutical policies, consistency evaluation, modified preparations, and international declaration strategy. The four major sectors will provide the most cutting-edge and most valuable communication opportunities for all enterprises.
Looking forward to welcoming you in Pharmacon 2019 !
Chemical companies and technology companies: R&D department, registration department, analysis and development department, preparation department, manufacturing department, quality department, Business Department and Clinical Department Head and Senior Management
Drug registration and regulatory experts
Clinical trial researchers, data managers, project managers, etc.
CRO, CMO and senior management of equipments
Main Forum |
|
|
Forum 1: Consistency Evaluation |
|
|
Forum 2: Modified Preparations |
|
|
Forum 3: Regulation Affair |
|
|
Refund Description: